Arcutis Biotherapeutics, Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc. for March 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 59,481 | 99,964 | 158,492 | |
Mar 16 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 59,481 | 99,964 | 566,928 | 507.4 K to 566.9 K (+11.72 %) |
Mar 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Option Exercise | M | 0.58 | 6,110 | 3,545 | 36,660 | |
Mar 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Buy | M | 0.58 | 6,110 | 3,545 | 159,992 | 153.9 K to 160 K (+3.97 %) |
Mar 04 2020 | ARQT | Arcutis Biotherape ... | Sun Ricky | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Mar 04 2020 | ARQT | Arcutis Biotherape ... | Sun Ricky | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Grant | A | 0.00 | 9,000 | 0 | 153,882 | 144.9 K to 153.9 K (+6.21 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | A | 27.61 | 65,000 | 1,794,650 | 65,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 507,447 | 478.4 K to 507.4 K (+6.06 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | Senior VP, Manufact ... | Option Exercise | A | 27.61 | 27,000 | 745,470 | 27,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | Senior VP, Manufact ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 108,965 | 100 K to 109 K (+9.00 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Grant | A | 0.00 | 9,000 | 0 | 279,279 | 270.3 K to 279.3 K (+3.33 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | A | 27.61 | 27,000 | 745,470 | 27,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | ESTES DANIEL | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 |